Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study
Abstract Background While the process of sepsis-induced immunosuppression is now well described in adults, very little information is available on immune functions in pediatric sepsis. The current study investigated this in children with septic shock by performing immunomonitoring, including both in...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-03-01
|
Series: | Annals of Intensive Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13613-018-0382-x |
id |
doaj-19d2a347e9a64405ae5151c779a34727 |
---|---|
record_format |
Article |
spelling |
doaj-19d2a347e9a64405ae5151c779a347272020-11-24T23:56:29ZengSpringerOpenAnnals of Intensive Care2110-58202018-03-018111010.1186/s13613-018-0382-xOccurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot studySolenn Remy0Karine Kolev-Descamps1Morgane Gossez2Fabienne Venet3Julie Demaret4Etienne Javouhey5Guillaume Monneret6Hospices Civils de Lyon, Paediatric Intensive Care Unit, Mother and Children University HospitalHospices Civils de Lyon, Paediatric Intensive Care Unit, Mother and Children University HospitalHospices Civils de Lyon, Immunology Laboratory, E. Herriot HospitalHospices Civils de Lyon, Immunology Laboratory, E. Herriot HospitalHospices Civils de Lyon, Immunology Laboratory, E. Herriot HospitalHospices Civils de Lyon, Paediatric Intensive Care Unit, Mother and Children University HospitalHospices Civils de Lyon, Immunology Laboratory, E. Herriot HospitalAbstract Background While the process of sepsis-induced immunosuppression is now well described in adults, very little information is available on immune functions in pediatric sepsis. The current study investigated this in children with septic shock by performing immunomonitoring, including both innate (monocyte human leukocyte antigen-DR, mHLA-DR, expression) and adaptive immunity (lymphocyte subsets count), as well as cytokine concentrations (IL-6, IL-8, IL-10, IL-1Ra, TNF-α, IFN-γ). Subsequent objectives were to assess the associations between inflammatory response, potential immunosuppression and secondary acquired infection occurrence. Methods Single-center prospective observational study, including children aged between 1 month and 18 years admitted to pediatric intensive care unit (PICU) for septic shock. Age-matched controls were children hospitalized for elective surgery without any infectious criteria. Blood was sampled at day 1–2, 3–5, and 7–9 after sepsis onset. mHLA-DR and lymphocyte subsets count were measured by flow cytometry and cytokine concentrations by Luminex technology. Results A total of 26 children and 30 controls were included. Patients had lymphopenia, and mHLA-DR levels were significantly lower than controls at each time point (p < 0.0001). All cytokines peaked at day 1–2. Children with secondary acquired infection had lower day 3–5 mHLA-DR and higher pro-inflammatory cytokine concentrations (IL-6, IL-8 and TNF-α) at day 1–2 compared to children without secondary acquired infection. Conclusions The higher initial inflammatory cytokine production was, the more innate immunity was altered, while evaluated by low mHLA-DR expression. Children with decreased mHLA-DR expression developed more secondary acquired infections. Upon confirmation in multicenter cohorts, these results pave the way for immunostimulation for the most immunosuppressed children in order to prevent nosocomial infections in PICU. Trial registration PedIRIS study NCT02848144. Retrospectively registered 28 July 2016http://link.springer.com/article/10.1186/s13613-018-0382-xSeptic shockImmunosuppression inducedChildren |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Solenn Remy Karine Kolev-Descamps Morgane Gossez Fabienne Venet Julie Demaret Etienne Javouhey Guillaume Monneret |
spellingShingle |
Solenn Remy Karine Kolev-Descamps Morgane Gossez Fabienne Venet Julie Demaret Etienne Javouhey Guillaume Monneret Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study Annals of Intensive Care Septic shock Immunosuppression induced Children |
author_facet |
Solenn Remy Karine Kolev-Descamps Morgane Gossez Fabienne Venet Julie Demaret Etienne Javouhey Guillaume Monneret |
author_sort |
Solenn Remy |
title |
Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study |
title_short |
Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study |
title_full |
Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study |
title_fullStr |
Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study |
title_full_unstemmed |
Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study |
title_sort |
occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study |
publisher |
SpringerOpen |
series |
Annals of Intensive Care |
issn |
2110-5820 |
publishDate |
2018-03-01 |
description |
Abstract Background While the process of sepsis-induced immunosuppression is now well described in adults, very little information is available on immune functions in pediatric sepsis. The current study investigated this in children with septic shock by performing immunomonitoring, including both innate (monocyte human leukocyte antigen-DR, mHLA-DR, expression) and adaptive immunity (lymphocyte subsets count), as well as cytokine concentrations (IL-6, IL-8, IL-10, IL-1Ra, TNF-α, IFN-γ). Subsequent objectives were to assess the associations between inflammatory response, potential immunosuppression and secondary acquired infection occurrence. Methods Single-center prospective observational study, including children aged between 1 month and 18 years admitted to pediatric intensive care unit (PICU) for septic shock. Age-matched controls were children hospitalized for elective surgery without any infectious criteria. Blood was sampled at day 1–2, 3–5, and 7–9 after sepsis onset. mHLA-DR and lymphocyte subsets count were measured by flow cytometry and cytokine concentrations by Luminex technology. Results A total of 26 children and 30 controls were included. Patients had lymphopenia, and mHLA-DR levels were significantly lower than controls at each time point (p < 0.0001). All cytokines peaked at day 1–2. Children with secondary acquired infection had lower day 3–5 mHLA-DR and higher pro-inflammatory cytokine concentrations (IL-6, IL-8 and TNF-α) at day 1–2 compared to children without secondary acquired infection. Conclusions The higher initial inflammatory cytokine production was, the more innate immunity was altered, while evaluated by low mHLA-DR expression. Children with decreased mHLA-DR expression developed more secondary acquired infections. Upon confirmation in multicenter cohorts, these results pave the way for immunostimulation for the most immunosuppressed children in order to prevent nosocomial infections in PICU. Trial registration PedIRIS study NCT02848144. Retrospectively registered 28 July 2016 |
topic |
Septic shock Immunosuppression induced Children |
url |
http://link.springer.com/article/10.1186/s13613-018-0382-x |
work_keys_str_mv |
AT solennremy occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy AT karinekolevdescamps occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy AT morganegossez occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy AT fabiennevenet occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy AT juliedemaret occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy AT etiennejavouhey occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy AT guillaumemonneret occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy |
_version_ |
1725458308666490880 |